Spontaneous in vivo differentiation of embryonic stem cell-derived pancreatic endoderm-like cells corrects hyperglycemia in diabetic mice

Transplantation

Volumn 91, Issue 1, 2011, Pages 11-20

  Raikwar, Sudhanshu P ^a   Zavazava, Nicholas ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b Immunology Graduate Program   (United States)

Author keywords

Bioluminescence imaging; Diabetes; ES cells; Insulin producing cells; Pancreatic endoderm like cells; Transplantation

Indexed keywords

ACTIVIN A; CHEMOKINE RECEPTOR CXCR4; STROMAL CELL DERIVED FACTOR 1ALPHA; TRANSCRIPTION FACTOR PDX 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EMBRYONIC STEM CELL; HYPERGLYCEMIA; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY CAPSULE; LIVER; MOUSE; NEPHRECTOMY; NONHUMAN; PANCREAS; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURIFICATION; STEM CELL TRANSPLANTATION;

ACTIVINS; ANIMALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; DIABETES MELLITUS, TYPE 1; EMBRYONIC STEM CELLS; ENDODERM; HOMEODOMAIN PROTEINS; HYPERGLYCEMIA; INSULIN-SECRETING CELLS; MICE; PANCREAS; PROMOTER REGIONS, GENETIC; RECEPTORS, CXCR4; TRANS-ACTIVATORS; TREATMENT OUTCOME;

EID: 78751647254     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181fdd98b     Document Type: Article

References (62)

1. Daneman D. Type 1 diabetes. Lancet 2006;367:847.
2. Eisenbarth GS. Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med 1986;314:1360.
3. Mathis D, Vence L, Benoist C. Beta-cell death during progression to diabetes. Nature 2001;414:792.
4. Skowera A, Ellis RJ, Varela-Calvino R, et al. CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope. J Clin Invest 2008;118:3390.
5. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000;343:230.
6. Shapiro AM, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006;355:1318.
7. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981;292:154.
8. Raikwar SP, Mueller T, Zavazava N. Strategies for developing therapeutic application of human embryonic stem cells. Physiology (Bethesda) 2006;21:19.
9. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145.
10. Aguayo-Mazzucato C, Bonner-Weir S. Stem cell therapy for type 1 diabetes mellitus. Nat Rev Endocrinol 2010;6:139.
11. Raikwar SP, Zavazava N. Insulin producing cells derived from embryonic stem cells: Are we there yet? J Cell Physiol 2009;218:256.
12. Lumelsky N, Blondel O, Laeng P, et al. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 2001;292:1389.
13. D'Amour KA, Agulnick AD, Eliazer S, et al. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol 2005;23:1534.
14. D'Amour KA, Bang AG, Eliazer S, et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol 2006;24:1392.
15. Kroon E, Martinson LA, Kadoya K, et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol 2008;26:443.
16. Zhou Q, Brown J, Kanarek A, et al. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 2008;455:627.
17. Shifrin AL, Chirmule N, Gao GP, et al. Innate immune responses to adenoviral vector-mediated acute pancreatitis. Pancreas 2005;30:122.
18. Yang Y, Nunes FA, Berencsi K, et al. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 1994;91:4407.
19. Yang Y, Ertl HC, Wilson JM. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1994;1:433.
20. Ianus A, Holz GG, Theise ND, et al. In vivo derivation of glucosecompetent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest 2003;111:843.
21. Lechner A, Yang YG, Blacken RA, et al. No evidence for significant transdifferentiation of bone marrow into pancreatic beta-cells in vivo. Diabetes 2004;53:616.
22. Taneera J, Rosengren A, Renstrom E, et al. Failure of transplanted bone marrow cells to adopt a pancreatic beta-cell fate. Diabetes 2006;55:290.
23. Hess D, Li L, Martin M, et al. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol 2003;21:763.
24. Thorel F, Nepote V, Avril I, et al. Conversion of adult pancreatic alphacells to beta-cells after extreme beta-cell loss. Nature 2010;464:1149.
25. Ahlgren U, Jonsson J, Jonsson L, et al. beta-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes. Genes Dev 1998;12:1763.
26. Holland AM, Gonez LJ, Naselli G, et al. Conditional expression demonstrates the role of the homeodomain transcription factor Pdx1 in maintenance and regeneration of beta-cells in the adult pancreas. Diabetes 2005;54:2586.
27. Holland AM, Hale MA, Kagami H, et al. Experimental control of pancreatic development and maintenance. Proc Natl Acad Sci USA 2002;99:12236.
28. Jonsson J, Carlsson L, Edlund T, et al. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 1994;371:606.
29. Offield MF, Jetton TL, Labosky PA, et al. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 1996;122:983.
30. Stoffers DA, Zinkin NT, Stanojevic V, et al. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat Genet 1997;15:106.
31. Gradwohl G, Dierich A, LeMeur M, et al. neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc Natl Acad Sci USA 2000;97:1607.
32. Gu G, Dubauskaite J, Melton DA. Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development 2002;129:2447.
33. Johansson KA, Dursun U, Jordan N, et al. Temporal control of neurogenin3 activity in pancreas progenitors reveals competence windows for the generation of different endocrine cell types. Dev Cell 2007;12:457.
34. Schwitzgebel VM, Scheel DW, Conners JR, et al. Expression of neurogenin3 reveals an islet cell precursor population in the pancreas. Development 2000;127:3533.
35. Smith SB, Qu HQ, Taleb N, et al. Rfx6 directs islet formation and insulin production in mice and humans. Nature 2010;463:775.
36. Soyer J, Flasse L, Raffelsberger W, et al. Rfx6 is an Ngn3-dependent winged helix transcription factor required for pancreatic islet cell development. Development 2010;137:203.
37. Kataoka K, Han SI, Shioda S, et al. MafA is a glucose-regulated and pancreatic beta-cell-specific transcriptional activator for the insulin gene. J Biol Chem 2002;277:49903.
38. Matsuoka TA, Artner I, Henderson E, et al. The MafA transcription factor appears to be responsible for tissue-specific expression of insulin. Proc Natl Acad Sci USA 2004;101:2930.
39. Olbrot M, Rud J, Moss LG, et al. Identification of beta-cell-specific insulin gene transcription factor RIPE3b1 as mammalian MafA. Proc Natl Acad Sci USA 2002;99:6737.
40. Collombat P, Xu X, Ravassard P, et al. The ectopic expression of Pax4 in the mouse pancreas converts progenitor cells into alpha and subsequently beta cells. Cell 2009;138:449.
41. Smith SB, Ee HC, Conners JR, et al. Paired-homeodomain transcription factor PAX4 acts as a transcriptional repressor in early pancreatic development. Mol Cell Biol 1999;19:8272.
42. Sosa-Pineda B, Chowdhury K, Torres M, et al. The Pax4 gene is essential for differentiation of insulin-producing beta cells in the mammalian pancreas. Nature 1997;386:399.
43. Wang J, Elghazi L, Parker SE, et al. The concerted activities of Pax4 and Nkx2.2 are essential to initiate pancreatic beta-cell differentiation. Dev Biol 2004;266:178.
44. Yasunaga M, Tada S, Torikai-Nishikawa S, et al. Induction and monitoring of definitive and visceral endoderm differentiation of mouse ES cells. Nat Biotechnol 2005;23:1542.
45. Kayali AG, Van GK, Campbell IL, et al. The stromal cell-derived factor-1alpha/CXCR4 ligand-receptor axis is critical for progenitor survival and migration in the pancreas. J Cell Biol 2003;163:859.
46. Sordi V, Malosio ML, Marchesi F, et al. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 2005;106:419.
47. Huang Y, Kucia M, Hussain LR, et al. Bone marrow transplantation temporarily improves pancreatic function in streptozotocin-induced diabetes: Potential involvement of very small embryonic-like cells. Transplantation 2010;89:677.
48. Raikwar SP, Zavazava N. Real-time non-invasive imaging of ES cellderived insulin producing cells. Methods Mol Biol 2009;590:317.
49. Segev H, Fishman B, Ziskind A, et al. Differentiation of human embryonic stem cells into insulin-producing clusters. Stem Cells 2004;22:265.
50. Chen X, Zhang X, Larson C, et al. Prolonging islet allograft survival using in vivo bioluminescence imaging to guide timing of antilymphocyte serum treatment of rejection. Transplantation 2008;85:1246.
51. Molano RD, Pileggi A, Song S, et al. Prolonged islet allograft survival by alpha-1 antitrypsin: The role of humoral immunity. Transplant Proc 2008;40:455.
52. Sakata N, Chan NK, Chrisler J, et al. Bone marrow cell cotransplantation with islets improves their vascularization and function. Transplantation 2010;89:686.
53. Sacco A, Doyonnas R, Kraft P, et al. Self-renewal and expansion of single transplanted muscle stem cells. Nature 2008;456:502.
54. Xie Y, Yin T, Wiegraebe W, et al. Detection of functional haematopoietic stem cell niche using real-time imaging. Nature 2009;457:97.
55. Rabinovich BA, Ye Y, Etto T, et al. Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancer. Proc Natl Acad Sci USA 2008;105:14342.
56. Bonde S, Pedram M, Stultz R, et al. Cell fusion of bone marrow cells and somatic cell reprogramming by embryonic stem cells. FASEB J 2010;24:364.
57. Edlund T, Walker MD, Barr PJ, et al. Cell-specific expression of the rat insulin gene: Evidence for role of two distinct 5′ flanking elements. Science 1985;230:912.
58. Walker MD, Edlund T, Boulet AM, et al. Cell-specific expression controlled by the 5′-flanking region of insulin and chymotrypsin genes. Nature 1983;306:557.
59. Chan KM, Raikwar SP, Zavazava N. Strategies for differentiating embryonic stem cells (ESC) into insulin-producing cells and development of non-invasive imaging techniques using bioluminescence. Immunol Res 2007;39:261.
60. Raikwar NS, Bowen-Deeg RF, Du XS, et al. Glycosylphosphatidylinositol- specific phospholipase D improves glucose tolerance. Metabolism 2010;59:1413.
61. Niswender KD, Blackman SM, Rohde L, et al. Quantitative imaging of green fluorescent protein in cultured cells: Comparison of microscopic techniques, use in fusion proteins and detection limits. J Microsc 1995;180(pt 2):109.
62. Toth ZE, Shahar T, Leker R, et al. Sensitive detection of GFP utilizing tyramide signal amplification to overcome gene silencing. Exp Cell Res 2007;313:1943.